Why Is GE HealthCare Stock Trading Soaring On Thursday?

Core Insights - GE HealthCare reported fourth-quarter adjusted EPS of $1.45, an increase from$1.18 a year ago, surpassing the consensus estimate of $1.26 [1] - The company achieved sales of$5.32 billion, nearly matching the consensus of $5.33 billion, reflecting a 2$19.7 billion, a 1% increase year-over-year on both reported and organic bases [2] - Net income attributable to GE HealthCare rose to $720 million from$403 million a year ago, while Adjusted EBIT increased to $994 million from$837 million [3] - The total company book-to-bill ratio was 1.09 times, with total orders increasing by 6% organically year-over-year [2] Management Commentary - GE HealthCare President and CEO Peter Arduini expressed satisfaction with the strong momentum in orders, backlog, and book-to-bill ratios observed in the fourth quarter [4] - The company continues to experience revenue growth driven by demand in AVS and PDx, alongside robust margin expansion and earnings growth [4] Future Guidance - GE HealthCare provided guidance for 2025, factoring in the impact of recently implemented U.S. tariffs on products from China [4] - The company anticipates organic revenue growth of 2% to 3% year-over-year, with an expected adjusted EBIT margin of 16.7%-16.8% [6] - Adjusted EPS is projected to be between $4.61 and$4.75, compared to the consensus of $4.66, with free cash flow expected to be at least$1.75 billion [6] Stock Performance - GEHC stock experienced a rise of 9.01%, reaching $93.64 during the last check on Thursday [5]